To extend our aetiological and applied health research in non-Western populations, we have selected Bangladesh as a key focus of our global vascular health efforts. Bangladesh is a South Asian nation (population ~160M million) with major unmet CVD needs and extreme levels of modifiable exposures that are established or emerging CVD risk factors. Our long-term goals are to:
- Define the relevance of modifiable risk factors to CVDs in Bangladesh
- create frameworks for randomised controlled trials (RCTs). CEU-led studies in Bangladesh include BRAVE (a case-control study that has recruited ~8000 MI cases and ~8000 controls) and BELIEVE, a community-based household survey of ~50,000 individuals (~8000 have been recruited by October 2016) that is collecting haematological, lifestyle, and clinical data, and stored plasma and DNA samples.